Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

482 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vaccine Breakthrough Infections by SARS-CoV-2 Variants after ChAdOx1 nCoV-19 Vaccination in Healthcare Workers.
Kale P, Gupta E, Bihari C, Patel N, Rooge S, Pandey A, Bajpai M, Khillan V, Chattopadhyay P, Devi P, Maurya R, Jha N, Mehta P, Kumar M, Sharma P, Saifi S, Swaminathan A, Alam S, Uppili B, Faruq M, Agrawal A, Pandey R, Sarin SK. Kale P, et al. Among authors: maurya r. Vaccines (Basel). 2021 Dec 31;10(1):54. doi: 10.3390/vaccines10010054. Vaccines (Basel). 2021. PMID: 35062715 Free PMC article.
Clinical, Serological, Whole Genome Sequence Analyses to Confirm SARS-CoV-2 Reinfection in Patients From Mumbai, India.
Shastri J, Parikh S, Agrawal S, Chatterjee N, Pathak M, Chaudhary S, Sharma C, Kanakan A, A V, Srinivasa Vasudevan J, Maurya R, Fatihi S, Thukral L, Agrawal A, Pinto L, Pandey R, Sunil S. Shastri J, et al. Among authors: maurya r. Front Med (Lausanne). 2021 Mar 9;8:631769. doi: 10.3389/fmed.2021.631769. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33768104 Free PMC article.
Respiratory Co-Infections: Modulators of SARS-CoV-2 Patients' Clinical Sub-Phenotype.
Mehta P, Sahni S, Siddiqui S, Mishra N, Sharma P, Sharma S, Tyagi A, Chattopadhyay P, Vivekanand A, Devi P, Khan A, Waghdhare S, Budhiraja S, Uppili B, Maurya R, Nangia V, Shamim U, Hazarika PP, Wadhwa S, Tyagi N, Dewan A, Tarai B, Das P, Faruq M, Agrawal A, Jha S, Pandey R. Mehta P, et al. Among authors: maurya r. Front Microbiol. 2021 May 28;12:653399. doi: 10.3389/fmicb.2021.653399. eCollection 2021. Front Microbiol. 2021. PMID: 34122366 Free PMC article.
Clinico-Genomic Analysis Reveals Mutations Associated with COVID-19 Disease Severity: Possible Modulation by RNA Structure.
Mehta P, Alle S, Chaturvedi A, Swaminathan A, Saifi S, Maurya R, Chattopadhyay P, Devi P, Chauhan R, Kanakan A, Vasudevan JS, Sethuraman R, Chidambaram S, Srivastava M, Chakravarthi A, Jacob J, Namagiri M, Konala V, Jha S, Priyakumar UD, Vinod PK, Pandey R. Mehta P, et al. Among authors: maurya r. Pathogens. 2021 Aug 31;10(9):1109. doi: 10.3390/pathogens10091109. Pathogens. 2021. PMID: 34578142 Free PMC article.
Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India.
Dhar MS, Marwal R, Vs R, Ponnusamy K, Jolly B, Bhoyar RC, Sardana V, Naushin S, Rophina M, Mellan TA, Mishra S, Whittaker C, Fatihi S, Datta M, Singh P, Sharma U, Ujjainiya R, Bhatheja N, Divakar MK, Singh MK, Imran M, Senthivel V, Maurya R, Jha N, Mehta P, A V, Sharma P, Vr A, Chaudhary U, Soni N, Thukral L, Flaxman S, Bhatt S, Pandey R, Dash D, Faruq M, Lall H, Gogia H, Madan P, Kulkarni S, Chauhan H, Sengupta S, Kabra S; Indian SARS-CoV-2 Genomics Consortium (INSACOG)‡; Gupta RK, Singh SK, Agrawal A, Rakshit P, Nandicoori V, Tallapaka KB, Sowpati DT, Thangaraj K, Bashyam MD, Dalal A, Sivasubbu S, Scaria V, Parida A, Raghav SK, Prasad P, Sarin A, Mayor S, Ramakrishnan U, Palakodeti D, Seshasayee ASN, Bhat M, Shouche Y, Pillai A, Dikid T, Das S, Maitra A, Chinnaswamy S, Biswas NK, Desai AS, Pattabiraman C, Manjunatha MV, Mani RS, Arunachal Udupi G, Abraham P, Atul PV, Cherian SS. Dhar MS, et al. Among authors: maurya r. Science. 2021 Nov 19;374(6570):995-999. doi: 10.1126/science.abj9932. Epub 2021 Oct 14. Science. 2021. PMID: 34648303 Free PMC article.
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19.
Ray Y, Paul SR, Bandopadhyay P, D'Rozario R, Sarif J, Raychaudhuri D, Bhowmik D, Lahiri A, Vasudevan JS, Maurya R, Kanakan A, Sharma S, Kumar M, Singh P, Roy R, Chaudhury K, Maiti R, Bagchi S, Maiti A, Perwez MM, Mondal A, Tewari A, Mandal S, Roy A, Saha M, Biswas D, Maiti C, Bhaduri R, Chakraborty S, Sarkar BS, Haldar A, Saha B, Sengupta S, Pandey R, Chatterjee S, Bhattacharya P, Paul S, Ganguly D. Ray Y, et al. Among authors: maurya r. Nat Commun. 2022 Jan 19;13(1):383. doi: 10.1038/s41467-022-28064-7. Nat Commun. 2022. PMID: 35046397 Free PMC article. Clinical Trial.
Learning From Biological and Computational Machines: Importance of SARS-CoV-2 Genomic Surveillance, Mutations and Risk Stratification.
Bhat S, Pandey A, Kanakan A, Maurya R, Vasudevan JS, Devi P, Chattopadhyay P, Sharma S, Khyalappa RJ, Joshi MG, Pandey R. Bhat S, et al. Among authors: maurya r. Front Cell Infect Microbiol. 2021 Dec 24;11:783961. doi: 10.3389/fcimb.2021.783961. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 35047415 Free PMC article.
482 results